Expression of connexin 26 in endometrial adenocarcinoma - Analysis of correlations with some anatomoclinical features

Folia Histochemica et Cytobiologica

Volumn 46, Issue 2, 2008, Pages 171-176

  Lesniewicz, Tomasz ^a   Kanczuga Khoda, Luiza ^a   Baltaziak, Marek ^a   Sulkowska, Mariola ^a   Ruthkowski, Ryszard ^a   Koda, Mariusz ^a   Sulkowski, Stanislaw ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Connexin 26; Endometrial cancer; Gap junction; Immunohistochemistry

Indexed keywords

CONNEXIN 26; GAP JUNCTION PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MENSTRUAL CYCLE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR VOLUME; ADENOCARCINOMA; ENDOMETRIUM; ENDOMETRIUM TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROTEIN TRANSPORT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CONNEXINS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; MIDDLE AGED; PROTEIN TRANSPORT;

EID: 48449091481     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-008-0026-3     Document Type: Article

References (35)

1. Kumar NM, Gilula NB. The gap junction communication channel. Cell. 1996;84:381-388.
2. Yamasaki H, Naus CC. Role of connexin genes in growth control. Carcinogenesis. 1996;17:1199-1213.
3. Martin PE, Evans WH. Incorporation of connexins into plasma membranes and gap junctions. Cardiovasc Res. 2004;62: 378-387.
4. Huang R, Lin Y, Wang CC, Gano J, Lin B, Shi Q, Boynton A, Burke J, Huang RP. Connexin 43 suppresses human glioblastoma cell growth by down-regulation of monocyte chemotactic protein 1, as discovered using protein array technology. Cancer Res. 2002;62:2806-2812.
5. Ozog MA, Bechberger JF, Naus CC. Ciliary neurotrophic factor (CNTF) in combination with its soluble receptor (CNTFRalpha) increases connexin43 expression and suppresses growth of C6 glioma cells. Cancer Res. 2002;62: 3544-3548
6. Sohl G, Willecke K. Gap junctions and the connexin protein family. Cardiovasc Res. 2004;62:228-232
7. Saito T, Oyamada M, Yamasaki H, Mori M, Kudo R. Co-ordinated expression of connexins 26 and 32 in human endometrial glandular epithelium during the reproductive cycle and the influence of hormone replacement therapy. Int J Cancer. 2004;73:479-485
8. Trosko JE, Ruch RJ. Cell-cell communication in carcinogenesis. Front Biosci. 2004;15:208-236
9. Trosko JE, Ruch RJ. Gap junctions as targets for cancer chemoprevention and chemotherapy. Curr Drug Targets. 2002;3:465-482
10. King TJ, Bertram JS. Connexins as targets for cancer chemoprevention and chemotherapy. Biochim Biophys Acta. 2005; 1719:146-160
11. Mesnil M, Asamoto M, Piccoli C, Yamasaki H. Possible molecular mechanism of loss of homologous and heterologous gap junctional intercellular communication in rat liver epithelial cell lines. Cell Adhes Commun. 1994;2:377-384
12. Cesen-Cummings K, Fernstrom MJ, Malkinson AM, Ruch RJ. Frequent reduction of gap junctional intercellular communication and connexin43 expression in human and mouse lung carcinoma cells. Carcinogenesis. 1998;19:61-67
13. Mehta PP, Perez-Stable C, Nadji M, Mian M, Asotra K, Roos BA. Suppression of human prostate cancer cell growth by forced expression of connexin genes. Dev Genet. 1999;24: 91-110
14. Mesnil M. Connexins and cancer. Biol Cell. 2002;94:493-500
15. Saito T, Nishimura M, Kudo R, Yamasaki H. Suppressed gap junctional intercellular communication in carcinogenesis of endometrium. Int J Cancer. 2001;93:317-323
16. Koda M, Sulkowski S, Garofalo C, Kanczuga-Koda L, Sulkowska M, Surmacz E 2003; Expression of the insulin-like growth factor-I receptor in primary breast cancer and lymph node metastases: correlations with oestrogen receptors alpha and beta. Horm Metab Res. 35:794-801
17. Farber E. The multistep nature of cancer development. Cancer Res. 1984;44:4217-4223
18. Wilgenbus KK, Kirkpatrick CJ, Knuechel R, Willecke K, Traub O. Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int J Cancer. 1992;51:522-529
19. Hanna EA, Umhauer S, Roshong SL, Piechocki MP, Fernstrom MJ, Fanning JD, Ruch RJ. Gap junctional intercellular communication and connexin43 expression in human ovarian surface epithelial cells and ovarian carcinomas in vivo and in vitro. Carcinogenesis. 1999;20:1369-1373
20. Kanczuga-Koda L, Sulkowski S, Koda M, Sulkowska M. Alterations in connexion 26 expression during colorectal carcinogenesis. Oncology. 2005;68:217-222
21. Bruzzone R, White TW, Paul DL. Connections with connexins: the molecular basis of direct intercellular signalling. Eur J Biochem. 1996;238:1-27
22. Kanczuga-Koda L, Sulkowski S, Koda M, Sobaniec-Lotowska M, Sulkowska M. Expression of connexins 26, 32 and 43 in the human colon - an immunohistochemical study. Folia Histochem Cytobiol. 2004;42:203-207
23. Defeijter AW, Matesic DF, Ruch RJ, Guan X, Chang CC, Trosko JE. Localization and function of the connexin 43 gap-junction protein in normal and various oncogene-expressing rat liver epithelial cells. Mol Carcinog. 1996;16:203-212
24. Kanczuga-Koda L, Sulkowski S, Lenczewski A, Koda M, Wincewicz A, Baltaziak M, Sulkowska M. Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J Clin Pathol. 2006;59:429-433
25. Kanczuga-Koda L, Sulkowski S, Tomaszewski J, Koda M, Sulkowska M, Przystapa W, Golaszewska J, Baltaziak M. Connexins 26 and 43 correlate with Bak, but not with Bcl-2 protein in breast cancer. Oncol Rep. 2005;14:325-329
26. Dubina MV, Iatckii NA, Popov DE, Vasil'ev SV, Krutovskikh VA. Connexin 43, but not connexin 32, is mutated at advanced stages of human sporadic colon cancer. Oncogene. 2002;21:4992-4996
27. Piechocki MP, Burk RD, Ruch RJ. Regulation of connexin32 and connexin43 gene expression by DNA methylation in rat liver cells. Carcinogenesis. 1999;20:401-406
28. Nei H, Saito T, Yamasaki H, Mizumoto H, Ito E, Kudo R. Nuclear localization of beta-catenin in normal and carcinogenic endometrium. Mol Carcinog. 1999;25:207-218
29. Shih HC, Shiozawa T, Miyamoto T, Kashima H, Feng YZ, Kurai M, Konishi I. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression. Anticancer Res. 2004;24;3843-3850
30. Krutovskikh VA, Troyanovsky SM, Piccoli C, Tsuda H, Asamoto M, Yamasaki H. Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumour cell growth in vivo. Oncogene. 2000;19:505-513
31. Olbina G, Eckhart W. Mutations in the second extracellular region of connexin 43 prevent localization to the plasma membrane, but do not affect its ability to suppress cell growth. Mol Cancer Res. 2003;1:690-700
32. Qin H, Shao Q, Curtis H, Galipeau J, Belliveau DJ, Wang T, Alaoui-Jamali MA, Laird DW. Retroviral delivery of connexin genes to human breast tumour cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J Biol Chem. 2002; 277:29132-29138
33. Zhang YW, Kaneda M, Morita I. The gap junction-independent tumor-suppressing effect of connexin 43. J Biol Chem. 2003;278:44852-44856
34. O'Brien TP, Lau LF. Expression of the growth factor-inducible immediate early gene cyr61 correlates with chondrogenesis during mouse embryonic development. Cell Growth Differ 1992;3:645-654
35. Kanczuga-Koda L, Sulkowski S, Koda M, Skrzydlewska E, Sulkowska M. Connexin 26 correlates with Bcl-xL and Bax proteins expression in colorectal cancer. World J Gastroenterol. 2005;11:1544-1548